Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30027118HIVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TVIS20007304HPVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TVIS20007305HPVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TVIS20007306HPVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TVIS20013263HPVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TVIS20021893HPVENSG00000196139.14protein_codingAKR1C3NoNo8644A0A0A0MSS8
P42330
TCGA Plot Options
Drug Information
GeneAKR1C3
DrugBank IDDB00328
Drug NameIndomethacin
Target IDBE0000592
UniProt IDP42330
Regulation Typeinhibitor
PubMed IDs14996743; 27486833
CitationsLovering AL, Ride JP, Bunce CM, Desmond JC, Cummings SM, White SA: Crystal structures of prostaglandin D(2) 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin. Cancer Res. 2004 Mar 1;64(5):1802-10.@@Adeniji A, Uddin MJ, Zang T, Tamae D, Wangtrakuldee P, Marnett LJ, Penning TM: Discovery of (R)-2-(6-Methoxynaphthalen-2-yl)butanoic Acid as a Potent and Selective Aldo-keto Reductase 1C3 Inhibitor. J Med Chem. 2016 Aug 25;59(16):7431-44. doi: 10.1021/acs.jmedchem.6b00160. Epub 2016 Aug 12.
GroupsApproved; Investigational
Direct ClassificationBenzoylindoles
SMILESCOC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O
PathwaysIndomethacin Action Pathway
PharmGKBPA449982
ChEMBLCHEMBL6